Traded May 29 · filed the same dayNot under a reported trading plan
Edwards Lifesciences's SVP, Corporate Controller sold $49K of Edwards Lifesciences shares. The filing does not indicate a pre-arranged trading plan.
Loading…
Traded May 12, 2026 · Filed May 12, 2026
The CEO of Edwards Lifesciences sold $2.77M of Edwards Lifesciences shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,766,762
Shares × reported transaction price
19 days after results of Apr 23, 2026, 72 days before results of Jul 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $79.73 on May 12, 2026, 10% above its 52-week low and 9% below its high, little changed over the previous 30 trading days
52-week range $72.65 (Oct 16, 2025) to $87.18 (Mar 2, 2026), 49% of the way up, from 251 adjusted closes. 30 trading days earlier: $79.50 on Mar 30, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Oct 14, 2024 in the U.S. District Court, C.D. California. A filing is an allegation, not a finding.
Dhimant Patel v. Edwards Lifesciences Corporation, docket 8:24-cv-02221, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.9% | −0.1% | +2.1% |
| 30 days | +4.6% | −0.1% | +4.7% |
| 90 days | +15.1% | +3.8% | +11.3% |
Past results only. Not a forecast.
Traded May 29 · filed the same dayNot under a reported trading plan
Edwards Lifesciences's SVP, Corporate Controller sold $49K of Edwards Lifesciences shares. The filing does not indicate a pre-arranged trading plan.
Traded May 27 · filed the same dayNot under a reported trading plan
Edwards Lifesciences's CVP,Strategy/Corp Development sold $2M of Edwards Lifesciences shares. The filing does not indicate a pre-arranged trading plan.
Traded May 22 · filed the same dayNot under a reported trading plan
Edwards Lifesciences's CVP, TMTT & Surgical sold $127K of Edwards Lifesciences shares. The filing does not indicate a pre-arranged trading plan.